These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 16740011

  • 1. Albumin-bound Paclitaxel in metastatic breast cancer: viewpoints.
    Davidson N, Ibrahim N, Harries M, Harper P.
    Drugs; 2006; 66(7):949-50. PubMed ID: 16740011
    [No Abstract] [Full Text] [Related]

  • 2. Albumin-bound Paclitaxel: in metastatic breast cancer.
    Robinson DM, Keating GM.
    Drugs; 2006; 66(7):941-8. PubMed ID: 16740010
    [Abstract] [Full Text] [Related]

  • 3. Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel.
    Petrelli F, Borgonovo K, Barni S.
    Expert Opin Pharmacother; 2010 Jun; 11(8):1413-32. PubMed ID: 20446855
    [Abstract] [Full Text] [Related]

  • 4. Treatment innovations for metastatic breast cancer: nanoparticle albumin-bound (NAB) technology targeted to tumors.
    Lluch A, Alvarez I, Muñoz M, Seguí MÁ, Tusquets I, García-Estévez L.
    Crit Rev Oncol Hematol; 2014 Jan; 89(1):62-72. PubMed ID: 24071503
    [Abstract] [Full Text] [Related]

  • 5. Update on nanoparticle albumin-bound paclitaxel.
    Socinski M.
    Clin Adv Hematol Oncol; 2006 Oct; 4(10):745-6. PubMed ID: 17099631
    [No Abstract] [Full Text] [Related]

  • 6. The role of albumin-bound paclitaxel in metastatic breast cancer.
    Russell C.
    Clin Adv Hematol Oncol; 2011 Jun; 9(6):469-71. PubMed ID: 21841747
    [No Abstract] [Full Text] [Related]

  • 7. Nanoparticle albumin-bound paclitaxel (ABI-007): a newer taxane alternative in breast cancer.
    Moreno-Aspitia A, Perez EA.
    Future Oncol; 2005 Dec; 1(6):755-62. PubMed ID: 16556053
    [Abstract] [Full Text] [Related]

  • 8. Clinical trials referral resource. Clinical trials with paclitaxel in metastatic breast cancer.
    Cheson BD, Abrams JS, Arbuck SG, Phillips PH.
    Oncology (Williston Park); 1994 Jan; 8(1):72-3, 76-7. PubMed ID: 7907222
    [No Abstract] [Full Text] [Related]

  • 9. A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancer.
    Yamamoto S, Maeda N, Nagashima Y, Kubo H, Sato Y, Matsui H, Inoue Y, Shindo Y, Kanekiyo S, Sakamoto K, Suzuki N, Takeda S, Ueno T, Yoshino S, Hazama S, Oka M, Nagano H.
    Breast Cancer; 2017 Nov; 24(6):783-789. PubMed ID: 28439763
    [Abstract] [Full Text] [Related]

  • 10. Nab-Paclitaxel monotherapy as a treatment of patients with metastatic breast cancer in routine clinical practice.
    Aigner J, Marmé F, Smetanay K, Schuetz F, Jaeger D, Schneeweiss A.
    Anticancer Res; 2013 Aug; 33(8):3407-13. PubMed ID: 23898112
    [Abstract] [Full Text] [Related]

  • 11. Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review.
    Montero AJ, Adams B, Diaz-Montero CM, Glück S.
    Expert Rev Clin Pharmacol; 2011 May; 4(3):329-34. PubMed ID: 22114779
    [Abstract] [Full Text] [Related]

  • 12. Albumin-bound paclitaxel improves response rate vs docetaxel in metastatic breast cancer.
    Oncology (Williston Park); 2007 Jan; 21(1):109. PubMed ID: 17313159
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An imagable and photothermal "Abraxane-like" nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors.
    Chen Q, Liang C, Wang C, Liu Z.
    Adv Mater; 2015 Feb 04; 27(5):903-10. PubMed ID: 25504416
    [Abstract] [Full Text] [Related]

  • 16. Nanoparticle albumin-bound paclitaxel for metastatic breast cancer.
    Harries M, Ellis P, Harper P.
    J Clin Oncol; 2005 Nov 01; 23(31):7768-71. PubMed ID: 16204007
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The winning formulation: the development of paclitaxel in pancreatic cancer.
    Ma WW, Hidalgo M.
    Clin Cancer Res; 2013 Oct 15; 19(20):5572-9. PubMed ID: 23918602
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Administration of low-dose albumin-bound paclitaxel for the treatment of advanced and recurrent breast cancer patients].
    Kawamura M, Nakano S, Kyoda S, Tabei I, Yoshida K, Takeyama H.
    Gan To Kagaku Ryoho; 2013 Jul 15; 40(7):909-12. PubMed ID: 23863734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.